Effectiveness of drug safety measures for reducing the incidence of adverse drug reactions: Post-hoc analysis of data from all-case surveillance of iguratimod using generalized estimating equations

• Kai Shibata ,

  Roles Conceptualization, Methodology, Project administration, Writing – original draft, Writing – review & editing

  * E-mail: k4-shibata@hhc.eisai.co.jp

  Affiliation Clinical Planning and Development Department, Medical HQ, Eisai Co., Ltd., Tokyo, Japan

  https://orcid.org/0000-0003-2341-660X

  ⨯
• Akiko Yoshimura,

  Roles Validation, Writing – review & editing

  Affiliation Clinical Planning and Development Department, Medical HQ, Eisai Co., Ltd., Tokyo, Japan

  ⨯
• Satoshi Ikeuchi,

  Roles Methodology, Writing – review & editing

  Affiliation Clinical Planning and Development Department, Medical HQ, Eisai Co., Ltd., Tokyo, Japan

  ⨯
• Mika Ishii

  Roles Writing – review & editing

  Affiliation Clinical Planning and Development Department, Medical HQ, Eisai Co., Ltd., Tokyo, Japan

  ⨯